NewslettersMesenchymal Cell NewsUmbilical & Placental Cell News Endogenous Follistatin-Like 1 Guarantees the Immunomodulatory Properties of Mesenchymal Stem Cells during Liver Fibrotic Therapy By lbeveridge - August 9, 2022 0 Investigators characterized the potential role of follistatin-like 1 in MSC-based anti-fibrotic therapy and further elucidated the mechanisms underlying its action. [Stem Cell Research & Therapy] Full Article